Back
Cognition Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33
CGTX
Cognition Therapeutics
Last Price:
0.43
Seasonality Move:
26.59%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CGTX is experiencing slight buying pressure.
Cognition Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.49 | Sell |
| 20-day SMA: | 0.5 | Sell |
| 50-day SMA: | 0.49 | Sell |
| 200-day SMA: | 1.4 | Sell |
| 8-day EMA: | 0.47 | Sell |
| 20-day EMA: | 0.49 | Sell |
| 50-day EMA: | 0.56 | Sell |
| 200-day EMA: | 1.15 | Sell |
Cognition Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 41.18 | Sell |
| Chaikin Money Flow: | 158137 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.46 - 0.56) | Sell |
| Bollinger Bands (100): | (0.28 - 1.36) | Sell |
Cognition Therapeutics Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cognition Therapeutics Stock
Is Cognition Therapeutics Stock a Buy?
- Cognition Therapeutics share price is 0.44 while CGTX 8-day simple moving average is 0.49, which is a Sell signal.
- The stock price of CGTX is 0.44 while Cognition Therapeutics 20-day SMA is 0.50, which makes it a Sell.
- Cognition Therapeutics 50-day simple moving average is 0.49 while CGTX share price is 0.44, making it a Sell technically.
- CGTX stock price is 0.44 and Cognition Therapeutics 200-day simple moving average is 1.40, creating a Sell signal.
CGTX Technical Analysis vs Fundamental Analysis
Sell
33
Cognition Therapeutics (CGTX)
is a Sell
Is Cognition Therapeutics a Buy or a Sell?
-
Cognition Therapeutics stock is rated a Sell
The current Cognition Therapeutics [CGTX] share price is $0.44. The Score for CGTX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Cognition Therapeutics Stock Info
Market Cap:
18.27M
Price in USD:
0.44
Share Volume:
503.16K
Cognition Therapeutics 52-Week Range
52-Week High:
2.95
52-Week Low:
0.34
Sell
33
Cognition Therapeutics (CGTX)
is a Sell
Cognition Therapeutics Share Price Forecast
-
What is the Cognition Therapeutics stock price today?
The Cognition Therapeutics stock price is 0.44 USD today. -
Will CGTX stock go up or go down?
Cognition Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Cognition Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cognition Therapeutics is overvalued.
Is Cognition Therapeutics Stock a Buy?
- Cognition Therapeutics share price is 0.44 while CGTX 8-day exponential moving average is 0.47, which is a Sell signal.
- The stock price of CGTX is 0.44 while Cognition Therapeutics 20-day EMA is 0.49, which makes it a Sell.
- Cognition Therapeutics 50-day exponential moving average is 0.56 while CGTX share price is 0.44, making it a Sell technically.
- CGTX stock price is 0.44 and Cognition Therapeutics 200-day simple moving average is 1.15, creating a Sell signal.
Fundamental Analysis of Cognition Therapeutics
Is Cognition Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.16 per share.
Technical Analysis of Cognition Therapeutics
Should I short Cognition Therapeutics stock?
- CGTX Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Cognition Therapeutics is a Sell
- Cognition Therapeutics Relative Strength Index (RSI) is 41.18, which suggest Cognition Therapeutics is oversold
- The Bollinger Bands (25) for Cognition Therapeutics is (0.46 - 0.56), which suggest Cognition Therapeutics is a Sell
- The Bollinger Bands (100) for Cognition Therapeutics is (0.28 - 1.36), which suggest Cognition Therapeutics is a Sell
* Cognition Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.